Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
Most research on fluid biomarkers for central nervous system (CNS) disorders has so far been performed using cerebrospinal fluid (CSF) as the biomarker source. CSF has the advantage of being closer to the brain than serum or plasma with a relative enrichment of CNS-specific proteins that are present...
Main Authors: | Andreasson, Ulf, Blennow, Kaj, Zetterberg, Henrik |
---|---|
Format: | Online |
Language: | English |
Published: |
Elsevier
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941042/ |
Similar Items
-
The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
by: Blennow, Kaj, et al.
Published: (2015) -
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
by: Cicognola, Claudia, et al.
Published: (2016) -
Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
by: Hölttä, Mikko, et al.
Published: (2013) -
Fluid biomarkers in Alzheimer’s disease – current concepts
by: Rosén, Christoffer, et al.
Published: (2013) -
Plasma tau levels in Alzheimer's disease
by: Zetterberg, Henrik, et al.
Published: (2013)